Globe Life (NYSE:GL) CEO Sells $2,657,941.80 in Stock

Key Points

  • Globe Life CEO James Matthew Darden sold 18,318 shares on March 4 at an average price of $145.10 for $2,657,941.80, leaving him with 51,093 shares valued at $7,413,594.30 and representing a 26.39% reduction in his holding.
  • He also sold 9,527 shares on February 27 at $144.34 for $1,375,127.18, bringing his recent insider sales to roughly $4.03 million across the two transactions.
  • Globe Life reported quarterly EPS of $3.39 (missing estimates), issued FY2026 guidance of 14.95–15.65 EPS, raised its quarterly dividend to $0.33 (annual $1.32, yield ~0.9%, ex-dividend Apr 2), and holds a consensus analyst rating of Moderate Buy with a $171.33 price target.

Globe Life Inc. (NYSE:GL - Get Free Report) CEO James Matthew Darden sold 18,318 shares of the company's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80. Following the sale, the chief executive officer owned 51,093 shares of the company's stock, valued at $7,413,594.30. This represents a 26.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

James Matthew Darden also recently made the following trade(s):

  • On Friday, February 27th, James Matthew Darden sold 9,527 shares of Globe Life stock. The shares were sold at an average price of $144.34, for a total value of $1,375,127.18.

Globe Life Stock Up 0.1%

GL opened at $144.89 on Thursday. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The firm has a 50 day moving average price of $142.03 and a 200 day moving average price of $138.89. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market cap of $11.39 billion, a PE ratio of 10.29 and a beta of 0.46.




Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts' consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the firm earned $3.14 earnings per share. The company's quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.9%. This is a boost from Globe Life's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life's dividend payout ratio is 7.67%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. MidFirst Bank acquired a new stake in shares of Globe Life in the 4th quarter valued at about $529,000. Compound Planning Inc. increased its holdings in shares of Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company's stock valued at $275,000 after acquiring an additional 82 shares during the last quarter. Invesco Ltd. lifted its stake in Globe Life by 2.7% during the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company's stock worth $552,262,000 after purchasing an additional 102,445 shares during the last quarter. Strive Financial Group LLC acquired a new position in Globe Life in the fourth quarter worth $1,974,000. Finally, Vident Advisory LLC boosted its holdings in Globe Life by 57.7% in the fourth quarter. Vident Advisory LLC now owns 19,650 shares of the company's stock worth $2,748,000 after purchasing an additional 7,189 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on GL. Piper Sandler reiterated an "overweight" rating and set a $167.00 target price on shares of Globe Life in a report on Friday, November 21st. Morgan Stanley reiterated an "overweight" rating and set a $176.00 price objective on shares of Globe Life in a research note on Monday, December 15th. Wells Fargo & Company boosted their target price on shares of Globe Life from $170.00 to $171.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 25th. Weiss Ratings raised shares of Globe Life from a "hold (c+)" rating to a "buy (b-)" rating in a report on Friday, February 13th. Finally, Truist Financial boosted their price objective on shares of Globe Life from $158.00 to $180.00 and gave the stock a "buy" rating in a report on Friday, February 6th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $171.33.

Read Our Latest Research Report on GL

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

See Also

Insider Buying and Selling by Quarter for Globe Life (NYSE:GL)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Globe Life?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Globe Life and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles